Abstract:Background: Fibroblast-like synoviocytes (FLSs) play a critical role in promoting synovial aggression and joint destruction in rheumatoid arthritis (RA). Cyclic GMP-AMP synthase (cGAS)/stimulator of interferon gene (STING) signaling plays an important role in controlling a series of cellular biological processes. However, it is still unclear whether cGAS/STING signaling regulates rheumatoid synovial aggression.Methods: Cell migration and invasion were detected using a Transwell chamber. Gene expression was measured using quantitative reverse transcription-polymerase chain reaction (qRT-PCR), and protein expression was detected by western blotting. Reactive oxygen species (ROS) levels were measured by 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) probe. F-actin staining and immunofluorescence assays were used to investigate lamellipodia formation and nuclear translocation, respectively. A severe combined immunodeficiency (SCID) mouse model was established to observe the migration and invasion of RA FLSs in vivo.Results: Our results showed that cytosolic double-stranded DNA (dsDNA)-induced cGAS/STING activation promoted the in vitro migration and invasion of RA FLSs. Moreover, RA FLSs treated with cGAS or STING short hairpin RNA (shRNA) exhibited reduced invasion into cartilage in the SCID model. Mechanistically, we determined that cGAS/STING activation leads to increased mitochondrial ROS levels, and thereby increases phosphorylation of mammalian sterile 20-like kinase 1 (MST1), a core component of the Hippo pathway, subsequently promoting activation of forkhead box1 (FOXO1). MST1 and FOXO1 knockdown also diminished the migration and invasion of RA FLSs.Conclusions: Our findings suggest that cGAS/STING signaling has an important role in regulating rheumatoid synovial aggression and that targeting cGAS/STING may represent a novel potential therapy for RA.

The role of cGAS-STING signaling in rheumatoid arthritis: from pathogenesis to therapeutic targets

cGAS-STING pathway in pathogenesis and treatment of osteoarthritis and rheumatoid arthritis

Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

cGAS/STING signaling in the regulation of rheumatoid synovial aggression

Updated roles of cGAS-STING signaling in autoimmune diseases

The triggers of the cGAS-STING pathway and the connection with inflammatory and autoimmune diseases

The role of the cGAS-STING signaling pathway in viral infections, inflammatory and autoimmune diseases

The cGAS–STING pathway as a therapeutic target in inflammatory diseases

Cellular functions of cGAS-STING signaling

Cgas–sting, an Important Signaling Pathway in Diseases and Their Therapy

Inhibitory targeting cGAS-STING-TBK1 axis: Emerging strategies for autoimmune diseases therapy

Small molecules targeting cGAS-STING pathway for autoimmune disease

Harnessing cGAS-STING axis for therapeutic benefits in systemic lupus erythematosus

Medicinal chemistry perspective on cGAS-STING signaling pathway with small molecule inhibitors

The Cgas-Sting Pathway: Post-translational Modifications and Functional Implications in Diseases

cGAS-STING signaling in cardiovascular diseases

The regulation of cGAS-STING signaling by RNA virus-derived components

Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response

Significance of the cGAS-STING Pathway in Health and Disease

Advances in cGAS-STING Signaling Pathway and Diseases